Prognostic value of unrelated atypical serum immunofixation patterns during multiple myeloma therapy.
Autologous stem cell transplantation (ASCT) is the gold standard therapy for suitable multiple myeloma (MM) patients after induction with high dose therapy. To date, the evidence of a reliable marker of prognosis in these cases remains scarce. Our aim was to evaluate appearance of unrelated atypical serum immunofixation patterns (ASIPs) as a marker of prognosis in MM patients submitted to ASCT. We retrospectively analysed data from 65 patients. Interestingly, we observed that presence of ASIPs was associated with longer progression-free survival and longer overall survival. Our results suggested that presence of ASIPs could be a novel marker of good prognosis in MM patients submitted to ASCT.
Cristina
C
Guimarães
Rui
R
Bergantim
Renata
R
Ramalho
Nuno
N
Couto
João T
JT
Guimarães
Fernanda
F
Trigo
D000368:Aged; D006801:Humans; D007136:Immunoglobulins / Q000097:blood*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology* / Q000401:mortality / Q000628:therapy; D011379:Prognosis; D012074:Remission Induction; D012189:Retrospective Studies; D033581:Stem Cell Transplantation; D015996:Survival Rate; D014182:Transplantation, Autologous
D007136:Immunoglobulins